Proteomic alterations in patients with atopic dermatitis

References

• Lee HH, Patel KR, Singam V, et al. A systematic review and meta-analysis of the prevalence and phenotype of adult-onset atopic dermatitis. J Am Acad Dermatol. 2019 Jun;80(6):1526–1532.e7. doi: 10.1016/j.jaad.2018.05.1241
   PubMed Web of Science ®Google Scholar
• Silverberg JI. Public health burden and epidemiology of atopic dermatitis. Dermatol Clin. 2017 Jul;35(3):283–289. doi: 10.1016/j.det.2017.02.002
   PubMed Web of Science ®Google Scholar
• Morelli P, Gaspari M, Gabriele C, et al. Proteomic analysis from skin swabs reveals a new set of proteins identifying skin impairment in atopic dermatitis. Exp Dermatol. 2021 Jun;30(6):811–819. doi: 10.1111/exd.14276
   PubMed Web of Science ®Google Scholar
• Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020 Aug 1;396(10247):345–360. doi: 10.1016/S0140-6736(20)31286-1
   PubMed Web of Science ®Google Scholar
• Esaki H, Brunner PM, Renert-Yuval Y, et al. Early-onset pediatric atopic dermatitis is T(H)2 but also T(H)17 polarized in skin. J Allergy Clin Immunol. 2016 Dec;138(6):1639–1651. doi: 10.1016/j.jaci.2016.07.013
   PubMed Web of Science ®Google Scholar
• Chan TC, Sanyal RD, Pavel AB, et al. Atopic dermatitis in Chinese patients shows T(H)2/T(H)17 skewing with psoriasiform features. J Allergy Clin Immunol. 2018 Sep;142(3):1013–1017. doi: 10.1016/j.jaci.2018.06.016
   PubMed Web of Science ®Google Scholar
• Czarnowicki T, He H, Krueger JG, et al. Atopic dermatitis endotypes and implications for targeted therapeutics. J Allergy Clin Immunol. 2019 Jan;143(1):1–11. doi: 10.1016/j.jaci.2018.10.032
   PubMed Web of Science ®Google Scholar
• Facheris P, Da Rosa JC, Pagan AD, et al. Age of onset defines two distinct profiles of atopic dermatitis in adults. Allergy. 2023 Apr 9;78(8):2202–2214. doi: 10.1111/all.15741
   PubMed Web of Science ®Google Scholar
• Sanyal RD, Pavel AB, Glickman J, et al. Atopic dermatitis in African American patients is TH2/TH22-skewed with TH1/TH17 attenuation. Ann Allergy Asthma Immunol. 2019;122(1):99–110. e6. doi: 10.1016/j.anai.2018.08.024
   PubMed Web of Science ®Google Scholar
• Guo Y, Luo L, Zhu J, et al. Multi-omics research strategies for psoriasis and atopic dermatitis. Int J Mol Sci. 2023 Apr 28;24(9):8018. doi: 10.3390/ijms24098018
   PubMed Web of Science ®Google Scholar
• Aslam B, Basit M, Nisar MA, et al. Proteomics: technologies and their applications. J Chromatogr Sci. 2017 Feb;55(2):182–196. doi: 10.1093/chromsci/bmw167
   PubMed Web of Science ®Google Scholar
• Bratu D, Boda D, Genomic CC. Epigenomic, transcriptomic, proteomic and metabolomic approaches in atopic dermatitis. Curr Issues Mol Biol. 2023 Jun 20;45(6):5215–5231. doi: 10.3390/cimb45060331
   PubMed Web of Science ®Google Scholar
• Pavel AB, Zhou L, Diaz A, et al. The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature. J Am Acad Dermatol. 2020 Mar;82(3):690–699. doi: 10.1016/j.jaad.2019.10.039
   PubMed Web of Science ®Google Scholar
• He H, Olesen CM, Pavel AB, et al. Tape-strip proteomic profiling of atopic dermatitis on dupilumab identifies minimally invasive biomarkers. Front Immunol. 2020;11:1768. doi: 10.3389/fimmu.2020.01768
   PubMed Web of Science ®Google Scholar
• Guttman-Yassky E, Bissonnette R, Ungar B, et al. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis. J Allergy Clin Immunol. 2019 Jan 01;143(1):155–172. doi: 10.1016/j.jaci.2018.08.022
   PubMed Web of Science ®Google Scholar
• Suárez- FariñFariñAs M, Dhingra N, Gittler J, et al. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. J Allergy Clin Immunol. 2013 Aug;132(2):361–370. doi: 10.1016/j.jaci.2013.04.046
   PubMed Web of Science ®Google Scholar
• Brunner PM, Israel A, Zhang N, et al. Early-onset pediatric atopic dermatitis is characterized by T(H)2/T(H)17/T(H)22-centered inflammation and lipid alterations. J Allergy Clin Immunol. 2018 Jun;141(6):2094–2106. doi: 10.1016/j.jaci.2018.02.040
   PubMed Web of Science ®Google Scholar
• Renert-Yuval Y, Del Duca E, Pavel AB, et al. The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adults. J Allergy Clin Immunol. 2021 Jul;148(1):148–163. doi: 10.1016/j.jaci.2021.01.001
   PubMed Web of Science ®Google Scholar
• Czarnowicki T, Esaki H, Gonzalez J, et al. Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)(+) TH2/TH1 cell imbalance, whereas adults acquire CLA(+) TH22/TC22 cell subsets. J Allergy Clin Immunol. 2015 Oct;136(4):941–951.e3. doi: 10.1016/j.jaci.2015.05.049
   PubMed Web of Science ®Google Scholar
• Czarnowicki T, Gonzalez J, Shemer A, et al. Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population. J allergy clin immunol. 2015 Jul 01;136(1):104–115.e7. doi: 10.1016/j.jaci.2015.01.020
   PubMed Web of Science ®Google Scholar
• He H, Li R, Choi S, et al. Increased cardiovascular and atherosclerosis markers in blood of older patients with atopic dermatitis. Ann Allergy Asthma Immunol. 2020 Jan;124(1):70–78. doi: 10.1016/j.anai.2019.10.013
   PubMed Web of Science ®Google Scholar
• Dyjack N, Goleva E, Rios C, et al. Minimally invasive skin tape strip RNA sequencing identifies novel characteristics of the type 2-high atopic dermatitis disease endotype. J Allergy Clin Immunol. 2018 Apr;141(4):1298–1309. doi: 10.1016/j.jaci.2017.10.046
   PubMed Web of Science ®Google Scholar
• He H, Bissonnette R, Wu J, et al. Tape strips detect distinct immune and barrier profiles in atopic dermatitis and psoriasis. J Allergy Clin Immunol. 2021 Jan;147(1):199–212. doi: 10.1016/j.jaci.2020.05.048
   PubMed Web of Science ®Google Scholar
• McAleer MA, Jakasa I, Hurault G, et al. Systemic and stratum corneum biomarkers of severity in infant atopic dermatitis include markers of innate and T helper cell-related immunity and angiogenesis. Br J Dermatol. 2019 Mar;180(3):586–596. doi: 10.1111/bjd.17088
   PubMed Web of Science ®Google Scholar
• Mikhaylov D, Del Duca E, Olesen CM, et al. Transcriptomic profiling of tape-strips from moderate to severe atopic dermatitis patients treated with dupilumab. Dermatitis. 2021 Oct 1;32(1s):S71–S80. doi: 10.1097/DER.0000000000000764
   PubMed Web of Science ®Google Scholar
• Yu L, Li L. Potential biomarkers of atopic dermatitis. Front Med. 2022;9:1028694. doi: 10.3389/fmed.2022.1028694
   Web of Science ®Google Scholar
• Mikhaylov D, Del Duca E, Guttman-Yassky E. Proteomic signatures of inflammatory skin diseases: a focus on atopic dermatitis. Expert Rev Proteomics. 2021 May 04;18(5):345–361. doi: 10.1080/14789450.2021.1935247
   PubMed Web of Science ®Google Scholar
• Renert-Yuval Y, Thyssen JP, Bissonnette R, et al. Biomarkers in atopic dermatitis-a review on behalf of the international eczema council. J Allergy Clin Immunol. 2021 Apr;147(4):1174–1190.e1. doi: 10.1016/j.jaci.2021.01.013
   PubMed Web of Science ®Google Scholar
• Brunner PM, He H, Pavel AB, et al. The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult long-standing disease. J Am Acad Dermatol. 2019 Aug;81(2):510–519. doi: 10.1016/j.jaad.2019.04.036
   PubMed Web of Science ®Google Scholar
• Brunner PM, Israel A, Leonard A, et al. Distinct transcriptomic profiles of early-onset atopic dermatitis in blood and skin of pediatric patients. Ann Allergy Asthma Immunol. 2019 Mar 01;122(3):318–330.e3. doi: 10.1016/j.anai.2018.11.025
   PubMed Web of Science ®Google Scholar
• Brunner PM, Suárez- Fariñas M, He H, et al. The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins. Sci Rep. 2017 Aug 18;7(1):8707. doi: 10.1038/s41598-017-09207-z
   PubMed Web of Science ®Google Scholar
• Beck LA, Thaçi D, Hamilton JD, et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med. 2014 Jul 10;371(2):130–139. doi: 10.1056/NEJMoa1314768
   PubMed Web of Science ®Google Scholar
• Facheris P, Jeffery J, Del Duca E, et al. The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment. Cell Mol Immunol. 2023 Mar 16;20(5):448–474. doi: 10.1038/s41423-023-00992-4
   PubMed Web of Science ®Google Scholar
• Guttman-Yassky E, Pavel AB, Zhou L, et al. GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis. J Allergy Clin Immunol. 2019 Aug;144(2):482–493.e7. doi: 10.1016/j.jaci.2018.11.053
   PubMed Web of Science ®Google Scholar
• Michelhaugh SA, Januzzi JL Jr. Finding a needle in a haystack: proteomics in heart failure. JACC Basic Transl Sci. 2020 Oct;5(10):1043–1053. doi: 10.1016/j.jacbts.2020.07.007
   PubMedGoogle Scholar
• Hammers CM, Tang HY, Chen J, et al. Research techniques made simple: mass spectrometry for analysis of proteins in dermatological research. J Invest Dermatol. 2018 Jun;138(6):1236–1242. doi: 10.1016/j.jid.2018.01.001
   PubMed Web of Science ®Google Scholar
• Guerrera IC, Kleiner O. Application of mass spectrometry in proteomics. Biosci Rep. 2005 Feb;25(1–2):71–93. doi: 10.1007/s10540-005-2849-x
   PubMed Web of Science ®Google Scholar
• Lind L, Ärnlöv J, Lindahl B, et al. Use of a proximity extension assay proteomics chip to discover new biomarkers for human atherosclerosis. Atherosclerosis. 2015 Sep;242(1):205–210. doi: 10.1016/j.atherosclerosis.2015.07.023
   PubMed Web of Science ®Google Scholar
• Assarsson E, Lundberg M, Holmquist G, et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLOS ONE. 2014;9(4):e95192. doi: 10.1371/journal.pone.0095192
   PubMed Web of Science ®Google Scholar
• Olink Explore 3072. 2023 [cited 2023 Jul 12/23]. Available from: https://olink.com/products-services/explore/
   Google Scholar
• Ren AH, Diamandis EP, Kulasingam V. Uncovering the depths of the human proteome: antibody-based technologies for ultrasensitive multiplexed protein detection and quantification. Mol Cell Proteomics. 2021;20:100155. doi: 10.1016/j.mcpro.2021.100155
   PubMed Web of Science ®Google Scholar
• Candia J, Cheung F, Kotliarov Y, et al. Assessment of variability in the SOMAscan assay. Sci Rep. 2017 Oct 27;7(1):14248. doi: 10.1038/s41598-017-14755-5
   PubMedGoogle Scholar
• Candia J, Daya GN, Tanaka T, et al. Assessment of variability in the plasma 7k SomaScan proteomics assay. Sci Rep. 2022 Oct 13;12(1):17147. doi: 10.1038/s41598-022-22116-0
   PubMed Web of Science ®Google Scholar
• Schultze AE, Konrad RJ, Credille KM, et al. Ultrasensitive cross-species measurement of cardiac troponin-I using the erenna immunoassay system. Toxicol Pathol. 2008 Oct;36(6):777–782. doi: 10.1177/0192623308322016
   PubMed Web of Science ®Google Scholar
• Kraemer S, Vaught JD, Bock C, et al. From SOMAmer-based biomarker discovery to diagnostic and clinical applications: a SOMAmer-based, streamlined multiplex proteomic assay. PLOS ONE. 2011;6(10):e26332. doi: 10.1371/journal.pone.0026332
   PubMed Web of Science ®Google Scholar
• Fischer SK, Joyce A, Spengler M, et al. Emerging technologies to increase ligand binding assay sensitivity. Aaps J. 2015 Jan;17(1):93–101. doi: 10.1208/s12248-014-9682-8
   PubMed Web of Science ®Google Scholar
• Yeung D, Ciotti S, Purushothama S, et al. Evaluation of highly sensitive immunoassay technologies for quantitative measurements of sub-pg/mL levels of cytokines in human serum. J Immunol Methods. 2016 Oct;437:53–63. doi: 10.1016/j.jim.2016.08.003
   PubMed Web of Science ®Google Scholar
• Shukla R, Santoro J, Bender FC, et al. Quantitative determination of human interleukin 22 (IL-22) in serum using singulex-erenna® technology. J Immunol Methods. 2013 Apr 30;390(1–2):30–34. doi: 10.1016/j.jim.2013.01.002
   PubMed Web of Science ®Google Scholar
• Chowdhury F, Williams A, Johnson P. Validation and comparison of two multiplex technologies, Luminex® and mesoscale discovery, for human cytokine profiling. J Immunol Methods. 2009 Jan 01;340(1):55–64. doi: 10.1016/j.jim.2008.10.002
   PubMed Web of Science ®Google Scholar
• Khalifian S, Raimondi G, Brandacher G. The use of luminex assays to measure cytokines. J Invest Dermatol. 2015 Apr;135(4):1–5. doi: 10.1038/jid.2015.36
   PubMedGoogle Scholar
• Tang H, Panemangalore R, Yarde M, et al. 384-well multiplexed luminex cytokine assays for lead optimization. J Biomol Screen. 2016 Jul;21(6):548–555. doi: 10.1177/1087057116644164
   PubMedGoogle Scholar
• DIAGNOSTICS MS. Spot the difference. 2013 [cited 2024 Mar 8]. Available from: www.mesoscale.com
   Google Scholar
• Kim WK, Cho HJ, Ryu SI, et al. Comparative proteomic analysis of peripheral blood mononuclear cells from atopic dermatitis patients and healthy donors. BMB Rep. 2008 Aug 31;41(8):597–603. doi: 10.5483/BMBRep.2008.41.8.597
   PubMed Web of Science ®Google Scholar
• Park YD, Jang HS, Kim SY, et al. Two-dimensional electrophoretic profiling of atopic dermatitis in primary cultured keratinocytes from patients. Proteomics. 2006 Feb;6(4):1362–1370. doi: 10.1002/pmic.200500277
   PubMed Web of Science ®Google Scholar
• Park YD, Kim SY, Jang HS, et al. Towards a proteomic analysis of atopic dermatitis: a two-dimensional-polyacrylamide gel electrophoresis/mass spectrometric analysis of cultured patient-derived fibroblasts. Proteomics. 2004 Nov;4(11):3446–3455. doi: 10.1002/pmic.200400998
   PubMed Web of Science ®Google Scholar
• Park YD, Lyou YJ, Yang JM. Detection of down-regulated acetaldehyde dehydrogenase 1 in atopic dermatitis patients by two-dimensional electrophoresis. Exp Dermatol. 2007 Feb;16(2):130–134. doi: 10.1111/j.1600-0625.2006.00524.x
   PubMed Web of Science ®Google Scholar
• Park YD, Lyou YJ, Yang JM. Two-dimensional electrophoresis analyses of atopic dermatitis and the chances to detect new candidate proteins by the variations in immobilized pH gradient strips. J Dermatol Sci. 2007 Jul;47(1):9–17. doi: 10.1016/j.jdermsci.2007.02.004
   PubMed Web of Science ®Google Scholar
• Yoon SW, Kim TY, Sung MH, et al. Comparative proteomic analysis of peripheral blood eosinophils from healthy donors and atopic dermatitis patients with eosinophilia. Proteomics. 2005 May;5(7):1987–1995. doi: 10.1002/pmic.200401086
   PubMed Web of Science ®Google Scholar
• He H, Del Duca E, Diaz A, et al. Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalities. J Allergy Clin Immunol. 2021 Apr;147(4):1369–1380. doi: 10.1016/j.jaci.2020.08.041
   PubMed Web of Science ®Google Scholar
• Wang J, Suárez- Fariñas M, Estrada Y, et al. Identification of unique proteomic signatures in allergic and non-allergic skin disease. Clin Exp Allergy. 2017 Nov;47(11):1456–1467. doi: 10.1111/cea.12979
   PubMed Web of Science ®Google Scholar
• Rojahn TB, Vorstandlechner V, Krausgruber T, et al. Single-cell transcriptomics combined with interstitial fluid proteomics defines cell type-specific immune regulation in atopic dermatitis. J Allergy Clin Immunol. 2020 Nov;146(5):1056–1069. doi: 10.1016/j.jaci.2020.03.041
   PubMed Web of Science ®Google Scholar
• Leonard A, Wang J, Yu L, et al. Atopic dermatitis endotypes based on allergen sensitization, reactivity to staphylococcus aureus antigens, and underlying systemic inflammation. J Allergy Clin Immunol Pract. 2020 Jan;8(1):236–247.e3. doi: 10.1016/j.jaip.2019.08.013
   PubMed Web of Science ®Google Scholar
• Szegedi K, Lutter R, Res PC, et al. Cytokine profiles in interstitial fluid from chronic atopic dermatitis skin. J Eur Acad Dermatol Venereol. 2015 Nov;29(11):2136–2144. doi: 10.1111/jdv.13160
   PubMed Web of Science ®Google Scholar
• Leung DYM, Bissonnette R, Kreimer S, et al. Dupilumab inhibits vascular leakage of blood proteins into atopic dermatitis skin. J Allergy Clin Immunol Pract. 2023 May;11(5):1421–1428. doi: 10.1016/j.jaip.2023.03.020
   PubMed Web of Science ®Google Scholar
• Del Duca E, Renert-Yuval Y, Pavel AB, et al. Proteomic characterization of atopic dermatitis blood from infancy to adulthood. J Am Acad Dermatol. 2023 May;88(5):1083–1093. doi: 10.1016/j.jaad.2022.12.050
   PubMed Web of Science ®Google Scholar
• Zhou X, Xiao B, Zeng J, et al. Identification of cofilin-1 as a novel biomarker of atopic dermatitis using iTRAQ quantitative proteomics. J Clin Lab Anal. 2022 Nov;36(11):e24751. doi: 10.1002/jcla.24751
   PubMed Web of Science ®Google Scholar
• Bae Y, Kim SJ. Serum Ceruloplasmin as a potential clinical biomarker in atopic dermatitis. Ann Dermatol. 2022 Aug;34(4):245–252. doi: 10.5021/ad.21.321
   PubMed Web of Science ®Google Scholar
• Chang CJ, Wang HQ, Zhang J, et al. Distinct proteomic profiling of plasma extracellular vesicles from moderate-to-severe atopic dermatitis patients. Clin Cosmet Investig Dermatol. 2021;14:1033–1043. doi: 10.2147/CCID.S325515
   PubMed Web of Science ®Google Scholar
• Thijs JL, Strickland I, Bruijnzeel-Koomen C, et al. Serum biomarker profiles suggest that atopic dermatitis is a systemic disease. J Allergy Clin Immunol. 2018 Apr;141(4):1523–1526. doi: 10.1016/j.jaci.2017.12.991
   PubMed Web of Science ®Google Scholar
• Suárez- Fariñas M, Tintle SJ, Shemer A, et al. Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. J Allergy Clin Immunol. 2011 Apr;127(4):954–64.e1–4. doi: 10.1016/j.jaci.2010.12.1124
   Web of Science ®Google Scholar
• Guttman-Yassky E, Diaz A, Pavel AB, et al. Use of tape strips to detect immune and barrier abnormalities in the skin of children with early-onset atopic dermatitis. JAMA Dermatol. 2019 Dec 1;155(12):1358–1370. doi: 10.1001/jamadermatol.2019.2983
   PubMed Web of Science ®Google Scholar
• Gittler JK, Shemer A, Suárez- Fariñfariñas M, et al. Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol. 2012;130(6):1344–1354. doi: 10.1016/j.jaci.2012.07.012
   PubMed Web of Science ®Google Scholar
• Tsoi LC, Rodriguez E, Stölzl D, et al. Progression of acute-to-chronic atopic dermatitis is associated with quantitative rather than qualitative changes in cytokine responses. J Allergy Clin Immunol. 2020 May;145(5):1406–1415. doi: 10.1016/j.jaci.2019.11.047
   PubMed Web of Science ®Google Scholar
• Garmhausen D, Hagemann T, Bieber T, et al. Characterization of different courses of atopic dermatitis in adolescent and adult patients. Allergy. 2013 Apr;68(4):498–506. doi: 10.1111/all.12112
   PubMed Web of Science ®Google Scholar
• Brunner PM, Guttman-Yassky E. Racial differences in atopic dermatitis. Ann Allergy Asthma Immunol. 2019 May 01;122(5):449–455. doi: 10.1016/j.anai.2018.11.015
   PubMed Web of Science ®Google Scholar
• Tokura Y. Extrinsic and intrinsic types of atopic dermatitis. J Dermatol Sci. 2010 Apr;58(1):1–7. doi: 10.1016/j.jdermsci.2010.02.008
   PubMed Web of Science ®Google Scholar
• Leung DY, Calatroni A, Zaramela LS, et al. The nonlesional skin surface distinguishes atopic dermatitis with food allergy as a unique endotype. Sci, trans med. 2019;11(480):eaav2685. doi: 10.1126/scitranslmed.aav2685
   PubMed Web of Science ®Google Scholar
• Goleva E, Calatroni A, LeBeau P, et al. Skin tape proteomics identifies pathways associated with transepidermal water loss and allergen polysensitization in atopic dermatitis. J Allergy Clin Immunol. 2020;146(6):1367–1378. doi: 10.1016/j.jaci.2020.04.022
   PubMed Web of Science ®Google Scholar
• Lang CCV, Masenga J, Semango G, et al. Evidence for different immune signatures and sensitization patterns in sub-Saharan African vs. Central European atopic dermatitis patients. J Eur Acad Dermatol Venereol. 2021;35(2):e140–e142. doi: 10.1111/jdv.16871
   PubMed Web of Science ®Google Scholar
• Wen H-C, Czarnowicki T, Noda S, et al. Serum from Asian patients with atopic dermatitis is characterized by TH2/TH22 activation, which is highly correlated with nonlesional skin measures. J Allergy Clin Immunol. 2018;142(1):324–328. e11. doi: 10.1016/j.jaci.2018.02.047
   PubMed Web of Science ®Google Scholar
• Hulshof L, Hack D, Hasnoe Q, et al. A minimally invasive tool to study immune response and skin barrier in children with atopic dermatitis. Br J Dermatol. 2019;180(3):621–630. doi: 10.1111/bjd.16994
   PubMed Web of Science ®Google Scholar
• Hou A, Silverberg JI. Predictors and age-dependent pattern of psychologic problems in childhood atopic dermatitis. Pediatr Dermatol. 2021 May;38(3):606–612. doi: 10.1111/pde.14588
   PubMed Web of Science ®Google Scholar
• Lee CY, Chen MH, Jeng MJ, et al. Longitudinal association between early atopic dermatitis and subsequent attention-deficit or autistic disorder: a population-based case-control study. Medicine (Baltimore). 2016 Sep;95(39):e5005. doi: 10.1097/MD.0000000000005005
   PubMed Web of Science ®Google Scholar
• Chen MH, Su TP, Chen YS, et al. Is atopy in early childhood a risk factor for ADHD and ASD? a longitudinal study. J Psychosom Res. 2014 Oct;77(4):316–321. doi: 10.1016/j.jpsychores.2014.06.006
   PubMed Web of Science ®Google Scholar
• Wan J, Mitra N, Hooper SR, et al. Association of atopic dermatitis severity with learning disability in children. JAMA Dermatol. 2021 Apr 14;157(6):1–7. doi: 10.1001/jamadermatol.2021.0008
   PubMed Web of Science ®Google Scholar
• Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66(Suppl 1):8–16. doi: 10.1159/000370220
   PubMed Web of Science ®Google Scholar
• Bannister MJ, Freeman S. Adult-onset atopic dermatitis. Australas J Dermatol. 2000 Nov;41(4):225–228. doi: 10.1046/j.1440-0960.2000.00442.x
   PubMedGoogle Scholar
• David E, Ungar B, Renert-Yuval Y, et al. The evolving landscape of biologic therapies for atopic dermatitis: present and future perspective. Clin Exp Allergy. 2023 Feb;53(2):156–172. doi: 10.1111/cea.14263
   PubMed Web of Science ®Google Scholar
• Sims JT, Chang CY, Higgs RE, et al. Insights into adult atopic dermatitis heterogeneity derived from circulating biomarker profiling in patients with moderate-to-severe disease. Exp Dermatol. 2021 Nov;30(11):1650–1661. doi: 10.1111/exd.14389
   PubMed Web of Science ®Google Scholar
• Rindler K, Krausgruber T, Thaler FM, et al. Spontaneously resolved atopic dermatitis shows melanocyte and immune cell activation distinct from healthy control skin. Front Immunol. 2021;12:630892. doi: 10.3389/fimmu.2021.630892
   PubMed Web of Science ®Google Scholar
• Berdyshev E, Kim J, Kim BE, et al. Stratum corneum lipid and cytokine biomarkers at age 2 months predict the future onset of atopic dermatitis. J Allergy Clin Immunol. 2023 May;151(5):1307–1316. doi: 10.1016/j.jaci.2023.02.013
   PubMed Web of Science ®Google Scholar
• Halling AS, Rinnov MR, Ruge IF, et al. Skin TARC/CCL17 increase precedes the development of childhood atopic dermatitis. J Allergy Clin Immunol. 2023 Jun;151(6):1550–1557.e6. doi: 10.1016/j.jaci.2022.11.023
   PubMed Web of Science ®Google Scholar
• Rinnov MR, Halling AS, Gerner T, et al. Skin biomarkers predict development of atopic dermatitis in infancy. Allergy. 2023 Mar;78(3):791–802. doi: 10.1111/all.15518
   PubMed Web of Science ®Google Scholar
• Thijs JL, Nierkens S, Herath A, et al. A panel of biomarkers for disease severity in atopic dermatitis. Clin Exp Allergy. 2015 Mar;45(3):698–701. doi: 10.1111/cea.12486
   PubMed Web of Science ®Google Scholar
• Wu KG, Li TH, Chen CJ, et al. Correlations of serum interleukin-16, total IgE, eosinophil cationic protein and total eosinophil counts with disease activity in children with atopic dermatitis. Int J Immunopathol Pharmacol. 2011 Jan;24(1):15–23. doi: 10.1177/039463201102400103
   PubMed Web of Science ®Google Scholar
• Ungar B, Garcet S, Gonzalez J, et al. An integrated model of atopic dermatitis biomarkers highlights the systemic nature of the disease. J Invest Dermatol. 2017 Mar;137(3):603–613. doi: 10.1016/j.jid.2016.09.037
   PubMed Web of Science ®Google Scholar
• Bissonnette R, Maari C, Forman S, et al. The oral janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate-to-severe atopic dermatitis: results from a randomized double-blind placebo-controlled study. Br J Dermatol. 2019 Oct;181(4):733–742. doi: 10.1111/bjd.17932
   PubMed Web of Science ®Google Scholar
• Chambers G, Lawrie L, Cash P, et al. Proteomics: a new approach to the study of disease. J Pathol. 2000 Nov;192(3):280–288. doi: 10.1002/1096-9896(200011)192:3<280:AID-PATH748>3.0.CO;2-L
   PubMed Web of Science ®Google Scholar
• Fredman G, Skov L, Mann M, et al. Towards precision dermatology: emerging role of proteomic analysis of the skin. Dermatology. 2022;238(2):185–194. doi: 10.1159/000516764
   PubMed Web of Science ®Google Scholar
• Cui M, Cheng C, Zhang L. High-throughput proteomics: a methodological mini-review. Lab Invest. 2022 Nov;102(11):1170–1181. doi: 10.1038/s41374-022-00830-7
   PubMed Web of Science ®Google Scholar
• Al-Amrani S, Al-Jabri Z, Al-Zaabi A, et al. Proteomics: concepts and applications in human medicine. World J Biol Chem. 2021 Sep 27;12(5):57–69. doi: 10.4331/wjbc.v12.i5.57
   PubMedGoogle Scholar
• Kim M, Del Duca E, Cheng J, et al. Crisaborole reverses dysregulation of the mild to moderate atopic dermatitis proteome toward nonlesional and normal skin. J Am Acad Dermatol. 2023 Apr 11;89(2):283–292. doi: 10.1016/j.jaad.2023.02.064
   PubMed Web of Science ®Google Scholar
• Bangert C, Rindler K, Krausgruber T, et al. Persistence of mature dendritic cells, T(H)2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4Rα blockade. Sci Immunol. 2021 Jan 22;6(55). doi: 10.1126/sciimmunol.abe2749
   PubMed Web of Science ®Google Scholar
• Clausen ML, Agner T, Lilje B, et al. Association of disease severity with skin microbiome and filaggrin gene mutations in adult atopic dermatitis. JAMA Dermatol. 2018 Mar 1;154(3):293–300. doi: 10.1001/jamadermatol.2017.5440
   PubMed Web of Science ®Google Scholar
• Broccardo CJ, Mahaffey S, Schwarz J, et al. Comparative proteomic profiling of patients with atopic dermatitis based on history of eczema herpeticum infection and staphylococcus aureus colonization. J Allergy Clin Immunol. 2011 Jan;127(1):186–193.e1–11. doi: 10.1016/j.jaci.2010.10.033
   Web of Science ®Google Scholar